Listed

Nephros Inc

NEPHNasdaqCIK 1196298HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$6.0mRevenue, Q2 FY2026, three months to 2026-06-30$6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 10, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$6.0mRevenue, Q2 FY2026, three months to 2026-06-30$6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure+36.2% on a year earlier
  • Gross margin66.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $4.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure+3.7 pts on a year earlier
  • Operating margin20.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure+14.5 pts on a year earlier
  • Net margin19.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure+14.5 pts on a year earlier
  • Diluted EPS$0.11Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure+450.0% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$6.0mGross margin 66.9%
Diluted EPS$0.11, Q2 FY2026
Free cash flow$1.3m, Q4 FY2024
Nephros Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$k3,518Revenue, Q3 FY2024, three months to 2024-09-30$3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure3,870Revenue, Q4 FY2024, three months to 2024-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure4,877Revenue, Q1 FY2025, three months to 2025-03-31$4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure4,419Revenue, Q2 FY2025, three months to 2025-06-30$4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure4,764Revenue, Q3 FY2025, three months to 2025-09-30$4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure4,729Revenue, Q4 FY2025, three months to 2025-12-31$4.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure5,212Revenue, Q1 FY2026, three months to 2026-03-31$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure6,017Revenue, Q2 FY2026, three months to 2026-06-30$6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Gross margin%61.1%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Revenue: $3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure64.0%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $2.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure64.7%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure63.2%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure61.2%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $2.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Revenue: $4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure58.4%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Revenue: $4.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure57.4%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure66.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $4.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Operating margin%5.9%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $206.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Revenue: $3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure8.2%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $317.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure11.6%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $566.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure5.6%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $248.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure6.6%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $314.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Revenue: $4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure0.4%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $18.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Revenue: $4.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure1.9%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $97.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure20.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Net margin%5.2%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $183.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Revenue: $3.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure9.0%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $349.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Revenue: $3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure11.4%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $558.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $4.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure5.4%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $237.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure7.1%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $337.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Revenue: $4.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figure1.3%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $62.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Revenue: $4.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figure2.7%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $140.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure19.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Revenue: $6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Diluted EPS$ per share0.02Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figurenot reported (Diluted EPS not reported)0.05Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure0.02Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure0.03Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001493152-25-021061.Report this figurenot reported (Diluted EPS not reported)0.01Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001493152-26-021701.Report this figure0.11Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001493152-26-036851.Report this figure
Free cash flow$k(623)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$623.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001493152-25-021061. Derived: 9-month figure less the 6-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001493152-25-021061. Derived: 9-month figure less the 6-month figure.Report this figure1,304Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001493152-26-009848. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$18.8mGross margin 61.9%
Diluted EPS$0.11, FY2025
Free cash flow−$547.0k, FY2024
Nephros Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m10.2Revenue, FY2021, twelve months to 2021-12-31$10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008716.Report this figure10.0Revenue, FY2022, twelve months to 2022-12-31$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0001493152-24-010107.Report this figure14.2Revenue, FY2023, twelve months to 2023-12-31$14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure14.2Revenue, FY2024, twelve months to 2024-12-31$14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure18.8Revenue, FY2025, twelve months to 2025-12-31$18.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure
Gross margin%55.1%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $5.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-23, accession 0001493152-23-008716.Revenue: $10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008716.Report this figure47.4%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $4.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-15, accession 0001493152-24-010107.Revenue: $10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0001493152-24-010107.Report this figure59.0%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $8.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-24, accession 0001641172-25-000234.Revenue: $14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure61.6%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $8.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001493152-26-009848.Revenue: $14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure61.9%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $11.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001493152-26-009848.Revenue: $18.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure
Operating margin%(31.8%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-23, accession 0001493152-23-008716.Revenue: $10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008716.Report this figure(43.5%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-15, accession 0001493152-24-010107.Revenue: $10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0001493152-24-010107.Report this figure(11.2%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0001641172-25-000234.Revenue: $14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure0.0%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $6.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848.Revenue: $14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure6.1%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848.Revenue: $18.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure
Net margin%(37.8%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-03-03, accession 0001493152-22-005976.Revenue: $10.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-23, accession 0001493152-23-008716.Report this figure(71.2%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$7.1m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2024-03-15, accession 0001493152-24-010107.Revenue: $10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0001493152-24-010107.Report this figure(11.1%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0001641172-25-000234.Revenue: $14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure0.5%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $74.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848.Revenue: $14.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure6.4%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001493152-26-009848.Revenue: $18.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure
Diluted EPS$ per share(0.41)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasicAndDiluted. 10-K filed 2022-03-03, accession 0001493152-22-005976.Report this figure(0.73)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-15, accession 0001493152-24-010107.Report this figure(0.15)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure0.01Diluted EPS, FY2024, twelve months to 2024-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure0.11Diluted EPS, FY2025, twelve months to 2025-12-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figure
Free cash flow$m(1.5)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-23, accession 0001493152-23-008716.Capital expenditure: $36.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-23, accession 0001493152-23-008716.Report this figure(3.4)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-15, accession 0001493152-24-010107.Capital expenditure: $137.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-15, accession 0001493152-24-010107.Report this figure0.8Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $827.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0001641172-25-000234.Capital expenditure: $75.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-24, accession 0001641172-25-000234.Report this figure(0.5)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$492.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001493152-26-009848.Capital expenditure: $55.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001493152-26-009848.Report this figurenot reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Nephros Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
WEXFORD CAPITAL LP2026-06-30$12.9m3,600,552Unchanged
Topline Capital Management, LLC2026-06-30$1.9m535,698Reduced−46,269
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$709.2k198,643Unchanged
MORGAN STANLEY2026-06-30$460.2k128,915Added+18,000
Cornerstone Capital, Inc.2026-06-30$459.5k128,700Unchanged
BARD ASSOCIATES INC2026-06-30$421.3k118,003Reduced−3,199
RENAISSANCE TECHNOLOGIES LLC2026-06-30$276.7k77,504Reduced−21,896
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$250.9k70,263Reduced−2,662
Mesirow Financial Investment Management, Inc.2026-06-30$214.2k60,000Reduced−60,000
HighTower Advisors, LLC2026-06-30$213.2k59,710Unchanged

Recent filings

All 805 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Nephros Inc, recent filings
FiledFormWhat it isAccession number
2026-10-1420:01 ETDEF 14AProxy statementPeriod 2026-10-140001493152-26-047012
2026-10-1320:01 ET8-K5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-26-046814
2026-09-1621:16 ETSCHEDULE 13D/AOwnership report, active investor, amended0001398344-26-017130
2026-08-1020:00 ET10-QQuarterly reportPeriod 2026-06-300001493152-26-036851
2026-08-0620:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-26-036331
2026-06-1521:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-028539
2026-05-0720:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-26-021734
2026-05-0720:00 ET10-QQuarterly reportPeriod 2026-03-310001493152-26-021701
2026-04-3020:05 ET10-K/AAnnual report, amendedPeriod 2025-12-310001493152-26-020416
2026-03-2720:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-013189

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 12, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1196298
Tickers
NEPH
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.